<doc>
  <docmeta id="113hr4502ih">
    <bill congress="113" type="hr" number="4502" version="ih"/>
    <revision size="1751" annotations="0" status="complete" id="5" commit-time="2014-05-12T20:25:20Z" committer="mbohmer" doc="113hr4502ih/5.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H6913FAAA9CC0435497372D846C529DFA" public-private="public">
	<metadata>
<dublinCore>
<dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">113 HR 4502 IH: Stop Meth Labs and Enhance Patient Access Act of 2014</dc:title>
<dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">U.S. House of Representatives</dc:publisher>
<dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2014-04-28</dc:date>
<dc:format xmlns:dc="http://purl.org/dc/elements/1.1/">text/xml</dc:format>
<dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">EN</dc:language>
<dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>2d Session</session>
		<legis-num>H. R. 4502</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20140428">April 28, 2014</action-date>
			<action-desc>
        <sponsor name-id="L000569">Mr. Luetkemeyer</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on the <committee-name committee-id="HJU00">Judiciary</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such
			 provisions as fall within the jurisdiction of the committee concerned</action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To authorize the Attorney General to exempt certain products from the requirements of subsections
			 (d) and (e) of section 310 of the Controlled Substances Act if it is not
			 practical to use such products in the illicit manufacture of
			 methamphetamine.</official-title>
	</form>
	<legis-body id="H9DF1D16CEE5D42B79D4303C98E53F99F" style="OLC">
		<section id="H316750D60CF64AC7AE8296B3CA0502B9" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the <quote>
          <short-title>
            <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Stop Meth Labs and Enhance Patient Access Act of 2014" proposed="true">Stop Meth Labs and Enhance Patient Access Act of 2014</cato:entity-ref>
          </short-title>
        </quote>.</text>
		</section>
    <section id="H97313FEDFE9F4302BBD785789433CBF7">
      <enum>2.</enum>
      <header>Exemption if it is not practical to use product in illicit manufacture of methamphetamine</header>
      <text display-inline="no-display-inline">
        <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Controlled Substances Act/s:310/ss:e/p:3">Section 310(e)(3) of the Controlled Substances Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/830">
          <cato:entity-ref entity-type="uscode" value="usc/21/830/e/3">21 U.S.C. 830(e)(3)</cato:entity-ref>
        </external-xref>)</cato:entity> is amended by striking <quote>if the Attorney General determines that the product cannot be used in the illicit manufacture of
			 methamphetamine</quote> and inserting <quote>if the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="1500" entity-type="federal-body">Attorney General</cato:entity-ref> determines that it is not practical by processes known to be employed by
			 clandestine laboratory operators to use the product in the illicit
			 manufacture of methamphetamine</quote>.</text>
		</section>
  </legis-body>
</bill>
</doc>